Michael H. Davidson to Controlled Clinical Trials as Topic
This is a "connection" page, showing publications Michael H. Davidson has written about Controlled Clinical Trials as Topic.
Connection Strength
0.109
-
Is it over for ezetimibe? Expert Rev Cardiovasc Ther. 2008 Jul; 6(6):781-3.
Score: 0.082
-
Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease risk. Diabetes Obes Metab. 2012 Jan; 14(1):30-9.
Score: 0.026